|
Don't Say That Word | home 
New Cancer Drugs To Watch
Matthew Herper and Robert Langreth, 01.23.04, 12:00 PM ET
Cancer kills 555,000 Americans annually. Some 42% of all experimental medicines target the disease, according to the investment bank Needham & Co. In September, we spotlighted five of these drugs--four remain on our watch list. (Click here for complete cancer drug watch list. But many other drugs are in development. Click on the image below to learn about the six new cancer treatments we have added to our watch list.
The drug that dropped off.
Last September, we took a look at 25 medicines in drug company pipelines that investors should keep an eye on. Not every one was a winner. Some have failed utterly, others have suffered disappointing setbacks. Click here for five drugs that have stumbled. Some we are removing from our watch list altogether; others may stage a comeback later this year and are still worth watching.
|